Therapixel’s Post

Our very own Pierre Fillard was a guest of the French President's last week! Read his thoughts on this momentous event below #AI #radiology #innovation

View profile for Pierre Fillard

Founder & CSO chez Therapixel

Last Friday, I was honored to be invited at Elysée by President Emmanuel Macron to discuss about Women's health, alongside the minister of women and men equality Aurore Bergé and minister of health Yannick NEUDER. I had the opportunity to directly interact with the President and raised the following points: ✅ AI for breast cancer screening saves lives. For the past couple of years, many studies have shown an increase in cancer detection rates without impacting or even reducing the false positives (i.e., preventing unnecessary follow-up examinations such as biopsies). This directly translates into earlier cancer detection, less stress for the women, and overall better patient care. ✅ 2nd read in France is highly inefficient. Most of the time it is not digitalized: 2nd readers read on films! I also mentioned to the president the IMA-L2 prospective trial we are conducting in region PACA. ✅ Despite best efforts, only 50% of women engage in breast cancer screening programs. While causes are multifactorial, I discuss with the President about our ongoing work on predicting the future risk of breast cancer using AI, and how this could translate into personalized screening programs and strengthen patient engagement. And many fruitful discussions and an amazing time with Pr Catherine UZAN, Dr Chrysoula Zacharopoulou, Hélène Antier, Dr Erick Petit, Salomé Berlioux, Dr Stephanie RIST, Dr Alexandre Vallée, Pr Martine Gilard, Pr Catherine Llorens-Cortes, and Dr Christelle Ratignier-Carbonneil. Therapixel is more than ever committed to improving Women's health. Early breast cancer detection saves lives! #SantéDesDemmes #dépistage

  • No alternative text description for this image
  • No alternative text description for this image
  • No alternative text description for this image

To view or add a comment, sign in

Explore topics